EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access · CC BY-NC 4.0

Gabapentin Extended Release Tablets in Healthy Subjects Under Fed Conditions: A Randomized, Open-Label, Two-Treatment, Two-Period, Two-Sequence, Single Dose, Crossover, Comparative Bioavailability Study

Sudershan Kumar, Arshad Khuroo, Sanjay Jagannath Gurule, Sachin Mehra, Hari Krishan Tiwari, Y Zala, Venkata Rama Rao Kamala, Madhu Kandukuri, Shruti Dharmadhikari, Prashant Devkare, Chintan Khandhedia

Drugs in R&D · 2026-06 · 26 (2) · 187-196

DOI: 10.1007/s40268-026-00547-8 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Drugs in R&D, online erschienen am 01.07.2026. Verfasst von Sudershan Kumar und 10 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacology and Pharmacokinetics, Sun Pharmaceutical Industries Limited, Gurgaon, India. Hauptthemen laut MEDLINE: Amines, gamma-Aminobutyric Acid, Cyclohexanecarboxylic Acids, Analgesics. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Sun Pharmaceutical Industries Limited, Mumbai, India..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aminesgamma-Aminobutyric AcidCyclohexanecarboxylic AcidsAnalgesicsHumansMaleCross-Over StudiesBiological AvailabilityDelayed-Action PreparationsTabletsAdultGabapentinYoung AdultArea Under CurveMiddle AgedHealthy VolunteersTherapeutic Equivalency

Substanzen

Delayed-Action PreparationsTabletsAminesGabapentingamma-Aminobutyric AcidCyclohexanecarboxylic AcidsAnalgesics

Autor:innen und Institutionen

  • Clinical Pharmacology and Pharmacokinetics, Sun Pharmaceutical Industries Limited, Gurgaon, India.
  • Clinical Pharmacology Unit, Sun Pharmaceutical Industries Limited, Gurgaon, India.
  • Formulation Department, Sun Pharma Advanced Research Company (SPARC) Ltd, Mumbai, India.
  • Medical Affairs and Clinical Research, Sun Pharma Laboratories Limited, Mumbai, India.
  • Medical Affairs and Clinical Research, Sun Pharmaceutical Industries Limited, Mumbai, India. PrashantH.Devkare@sunpharma.com.

Förderung

  • Sun Pharmaceutical Industries Limited, Mumbai, India.

Zitieren

APA

Kumar, S., Khuroo, A., Gurule, S. J., Mehra, S., Tiwari, H. K., Zala, Y., Kamala, V. R. R., Kandukuri, M., Dharmadhikari, S., Devkare, P., & Khandhedia, C. (2026). Gabapentin Extended Release Tablets in Healthy Subjects Under Fed Conditions: A Randomized, Open-Label, Two-Treatment, Two-Period, Two-Sequence, Single Dose, Crossover, Comparative Bioavailability Study. Drugs in R&D, 26(2), 187-196. https://doi.org/10.1007/s40268-026-00547-8

Vancouver

Kumar S, Khuroo A, Gurule SJ, Mehra S, Tiwari HK, Zala Y, et al. Gabapentin Extended Release Tablets in Healthy Subjects Under Fed Conditions: A Randomized, Open-Label, Two-Treatment, Two-Period, Two-Sequence, Single Dose, Crossover, Comparative Bioavailability Study. Drugs in R&D. 2026;26(2):187-196. doi:10.1007/s40268-026-00547-8

BibTeX
@article{Kumar2026,
  author = {Kumar, Sudershan and Khuroo, Arshad and Gurule, Sanjay Jagannath and Mehra, Sachin and Tiwari, Hari Krishan and Zala, Y and Kamala, Venkata Rama Rao and Kandukuri, Madhu and Dharmadhikari, Shruti and Devkare, Prashant and Khandhedia, Chintan},
  title = {Gabapentin Extended Release Tablets in Healthy Subjects Under Fed Conditions: A Randomized, Open-Label, Two-Treatment, Two-Period, Two-Sequence, Single Dose, Crossover, Comparative Bioavailability Study},
  journal = {Drugs in R&D},
  year = {2026},
  volume = {26},
  number = {2},
  pages = {187--196},
  doi = {10.1007/s40268-026-00547-8}
}
Kostenlos starten →